Buruli ulcer

Research priorities

Among the many potentially important areas of research on Buruli ulcer, five priority areas by the Buruli ulcer community.

These are:

  1. The mode of transmission
  2. Development of methods for early diagnosis
  3. Drug treatment and new treatment modalities
  4. Cultural and socio-economic studies
  5. Incidence, prevalence and mapping of Buruli ulcer

1. The mode of transmission

Over 70 years of experience have established the fact that Buruli ulcer is acquired through exposure to the environment, particularly through exposure to slow-moving or stagnant bodies of water. However, the exact mode of transmission is still unknown. The importance of understanding the mechanism of transmission from the environment to human is obvious: if one can determine where the bacteria replicate, and how they are introduced into the patient, it may be possible to design public health interventions to prevent exposure to infection.

Isolation of M. ulcerans by cultures from samples taken from the environment has been difficult.  However, knowledge about transmission has increased due to the use of new molecular tools such as polymerase chain reaction (PCR).

Research so far has suspected the potential role of some insects and domestic animals in the transmission cycle due to the finding of  DNA of M. ulcerans. Water bugs in Africa and mosquitoes in Australia have been implicated in various transmission studies. However, none of these studies have established direct transmission to humans. Studies to understand the mode of transmission is a priority.


2. Development of methods for early diagnosis

Although Buruli ulcer can be confirmed in tertiary research laboratories equipped with modern techniques including culture, PCR and histopathology, today there are no simple and rapid tools for early diagnosis that can be implemented at the primary health care level of endemic countries.  Recently, other methods such as the fluorescent thin layer chromatography to detect mycolactone in tissue is also being evaluated at the district level.

Research to develop a point-of-care test is in progress. If successful, it would facilitate early diagnosis of Buruli ulcer at the primary health care and community levels to enable early initiation of antibiotic treatment to achieve the best outcomes for the patients.


3. Drug treatment and new treatment modalities

For several decades, surgery was the only treatment of Buruli ulcer often involving wide excision and skin grafting. Amputation was also common in severe forms of the disease. In 2004, following extensive research, WHO issued a provisional guidance on the use of rifampicin and streptomycin given daily for 8 weeks. For the first time, antibiotics were used to treat the disease: small lesions healed without surgery and for the large lesions, limited rather than radical surgery was possible. However, given the painful nature of the injection of streptomycin and its side effects, research continued until a completely oral combination was found. In 2020, research results published in the Lancet showed that a combination of rifampicin and clarithromycin for 8 weeks was as good as the rifampicin and streptomycin regimen. WHO now recommends rifampicin and clarithromycin for 8 weeks as the standard treatment. 

The next research priority is to find new treatments that can shorten the duration of treatment.

4. Cultural and socio-economic studies

Patients’ perceptions about a disease, its effective treatment, and the socio-economic dislocation caused by the illness and related symptoms, generally have a significant impact on when and where to go for diagnosis and treatment. Today, a significant number of people affected by Buruli ulcer still seek treatment too late. There are multiple reasons ranging from beliefs to problems of access to treatment.

Although these beliefs can vary considerably from culture to culture, there are some general common traits, which include:

  • If a disease does not follow its expected course, (e.g. “wounds that do not heal”) a supernatural cause such as a curse or witchcraft is often suspected. In such cases, patients seek supernatural cure.
  • People with limited resources (particularly those in rural areas) seek medical help first from the least expensive and the closest sources of care. Multiple, simultaneous or sequential sources of care may also be sought (e.g., home treatment, traditional and spiritual healers, before going to the hospital).
  • Local understanding of what constitutes a “severe” disease (or in the case of Buruli ulcer, a severe skin lesion).
  • Perceived lack of immediate threat to the individual.


In general, the aim of studies in this area is two-fold:

  • to assist in the design and evaluation of specific culturally appropriate and behaviorally feasible prevention and treatment interventions;
  • to inform policymakers to incorporate findings of such studies in designing and changing policies aimed at managing the disease.


Possible research areas include:

  • To determine local explanatory models of skin disorders and Buruli ulcer in particular (signs, causes, relative severities, treatments, perceived threat), local terminology associated with Buruli ulcer, patterns of health-seeking behavior (use of home remedies, traditional healers, local clinics and pharmacies, and other therapeutic resources), and factors influencing these patterns of health-seeking behaviour;
  • To determine community opinions of any proposed interventions such as health education, treatment, and community-based rehabilitation;
  • To determine the potential role of traditional healers in the early recognition and treatment of Buruli ulcer and the possible use of home and traditional remedies 
  • To encourage cooperation between traditional healers and health care providers to improve early detection and care for patients with Buruli ulcer;
  • To determine the socio-economic dislocations of social and cultural norms caused by Buruli ulcer and the coping strategies employed by affected people and their family members;
  • To determine the impact of Buruli ulcer (including disability) on the lives of the patients and family members;
  • To determine the costs of both static (or facility-based) and outreach management of Buruli ulcer. This will include both direct and indirect costs of such management strategies. Such costs studies should also include the assessment of the costs of treatment of various forms of the disease;
  • To determine the economic impact of the disease treatment on the health system, the community and the country at large.

5. Incidence, prevalence and mapping of Buruli ulcer

How common is Buruli ulcer? Where does it occur? How important is Buruli ulcer compared with other diseases? Is Buruli ulcer moving to new, previously disease-free areas?

There is evidence that Buruli ulcer is gradually increasing in incidence in some countries and reducing in other places and so is its geographic spread. The disease can suddenly appear in a new area which has previously been free or silent for a long time. However, because most cases of Buruli ulcer occur in poor rural communities in sub-Saharan Africa and other developing countries, surveillance of the disease may be poor and under-reporting could be widespread. 

Many theories have been proposed to explain the emergence of Buruli ulcer – such as mining, damming of rivers and deforestation. But we cannot test these theories unless we can accurately map the location and incidence of Buruli ulcer.

Priority areas for research therefore include the mapping of the disease and the estimate of prevalence and incidence in endemic countries.

 

Related publications

Institutions involved in Buruli ulcer research activities

Related links